Deal type reports

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.